AJP - Heart and Circulatory Physiology, Vol 266, Issue 1 128-H136, Copyright © 1994 by American Physiological Society

ARTICLES

Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil-released mediators

M. Buerke, A. S. Weyrich and A. M. Lefer
Department of Physiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.

We exposed isolated rat cardiac myocytes to 20 min of hypoxia followed by 20 min of reoxygenation and observed the effect of supernatants of stimulated neutrophils [polymorphonuclear leukocytes (PMNs)] given at the beginning of reoxygenation. PMN supernatants induced cardiac myocyte injury, which was characterized by a significant (P < 0.01) reduction in cell viability to 53 +/- 3%, vs. 84 +/- 3% in rat myocytes subjected to hypoxia-reoxygenation (H/R) alone. The PMN supernatants also resulted in elevated creatine kinase (CK) activities in the myocyte medium. To examine specific PMN-released mediators that may contribute to this cell death, we studied the effects of hydrogen peroxide (H2O2), elastase, and platelet-activating factor on H/R cardiac myocytes. Incubation of myocytes after hypoxia with 10, 50, and 100 microM H2O2 decreased viability in a concentration-dependent manner (from 83 +/- 2 to 37 +/- 2%; P < 0.01). CK release of H/R myocytes was also significantly increased by 100 microM H2O2 (to 28 +/- 5 from 12 +/- 1% for H/R alone; P < 0.01). Similarly, elastase (5 micrograms/ml) given after hypoxia significantly reduced cardiac myocyte viability during reoxygenation (viability 58 +/- 1 vs. 85 +/- 1% H/R alone; P < 0.05) and increased CK release (to 29 +/- 3 from 11 +/- 1% for H/R alone; P < 0.01), an effect that was abolished by L-680,833, an elastase inhibitor. Unlike H2O2 and elastase, platelet-activating factor had no significant effect on myocyte viability or CK release after H/R.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. Phillipson, E. E. Peterman, P. Taormina Jr., M. Harvey, R. J. Brue, N. Atkinson, D. Omiyi, U. Chukwu, and L. H. Young Protein kinase C-{zeta} inhibition exerts cardioprotective effects in ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H898 - H907. [Abstract] [Full Text] [PDF]

				J. R. Sowers Insulin resistance and hypertension Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1597 - H1602. [Abstract] [Full Text] [PDF]

				D. Pruefer, J. Makowski, M. Dahm, S. Guth, H. Oelert, H. Darius, and M. Buerke Aprotinin inhibits leukocyte-endothelial cell interactions after hemorrhage and reperfusion Ann. Thorac. Surg., January 1, 2003; 75(1): 210 - 215. [Abstract] [Full Text] [PDF]

				D. Pruefer, U. Buerke, M. Khalil, M. Dahm, H. Darius, H. Oelert, and M. Buerke Cardioprotective effects of the serine protease inhibitor aprotinin after regional ischemia and reperfusion on the beating heart J. Thorac. Cardiovasc. Surg., November 1, 2002; 124(5): 942 - 949. [Abstract] [Full Text] [PDF]

				L. H. Young, Y. Ikeda, and A. M. Lefer Caveolin-1 peptide exerts cardioprotective effects in myocardial ischemia-reperfusion via nitric oxide mechanism Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2489 - H2495. [Abstract] [Full Text] [PDF]

				L. H. Young, Y. Ikeda, R. Scalia, and A. M. Lefer Wortmannin, a Potent Antineutrophil Agent, Exerts Cardioprotective Effects in Myocardial Ischemia/Reperfusion J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 37 - 43. [Abstract] [Full Text]

				L. H. Young, Y. Ikeda, R. Scalia, and A. M. Lefer C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1453 - H1459. [Abstract] [Full Text] [PDF]

				A. M. Lefer, B. Campbell, Y.-K. Shin, R. Scalia, R. Hayward, and D. J. Lefer Simvastatin Preserves the Ischemic-Reperfused Myocardium in Normocholesterolemic Rat Hearts Circulation, July 13, 1999; 100(2): 178 - 184. [Abstract] [Full Text] [PDF]

				P. R. Hansen Role of Neutrophils in Myocardial Ischemia and Reperfusion Circulation, March 15, 1995; 91(6): 1872 - 1885. [Abstract] [Full Text]

				M. Buerke, T. Murohara, and A. M. Lefer Cardioprotective Effects of a C1 Esterase Inhibitor in Myocardial Ischemia and Reperfusion Circulation, January 15, 1995; 91(2): 393 - 402. [Abstract] [Full Text]